Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

RELATIONSHIP BETWEEN CD34/CD45 POSITIVE CELLS CONCENTRATION IN BLOOD OF HEART RECIPIENTS AND LEVEL OF GRAFT VASCULOPATHY RISK BIOMARKERS

https://doi.org/10.15825/1995-1191-2013-2-44-49

Abstract

Aim. To determine the relationship between CD34/CD45 positive cells number in peripheral blood before and after heart transplantation (HTx) and plasma level of the biomarkers. Materials and methods. We studied 27 pts. (23 men; 40 ± 13 years) with heart failure caused by dilated (17 cases) or ischemic cardiomyopathy (10 cases) before and after HTx. CD34/CD45 positive cells were measured in peripheral blood before and 2–4 days after the operation by flow cytometry and expressed in number of the cells per 106 events, plasma level of the biomar- kers – by ELISA. Results. The number of CD34/CD45+ cells in pts. with heart failure (224 ± 166) was similar to those in healthy individuals (233 ± 120) and there was no significant difference in the cell number between pts. with dilated (253 ± 188) and ischemic cardiomyopathy (169 ± 100). The cell number did not correlate with age, sex, body weight, blood cells counts and preoperative levels of the biomarkers: PlGF, sCD40L, PAPP-A. In 2–5 days after HTx the cell number decreased to 103 ± 102. The cell number after HTx did not correlate with demographic and laboratory parameters, anesthesia, operation, ischemia and hypothermia duration, blood loss volume and preoperative levels of PlGF and PAPP-A but correlated with sCD40L level in pts. with ischemic cardiomyopathy. Conclusion: Circulating HSC number in patients with heart failure does not differ from those in healthy individuals and decreases after HTx. In patients with ischemic cardiomyopathy the cell number after transplantation associates with preoperative level of sCD40L – the negative predictor of vasculopathy. 

About the Authors

O. P. Shevchenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation


R. M. Kurabekova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation


E. V. Naumova
Department clinical laboratory diagnostic (Head – prof. V.V. Dolgov) Russian Medical Academy of Postgraduate Education (Rector – academician of RAMSci, prof. L.K. Moshetova), Moscow, Russian Federation


S. A. Lugovskaya
Department clinical laboratory diagnostic (Head – prof. V.V. Dolgov) Russian Medical Academy of Postgraduate Education (Rector – academician of RAMSci, prof. L.K. Moshetova), Moscow, Russian Federation


E. A. Spirina
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation


V. N. Poptsov
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation


G. A. Olefirenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs (Head – academician of RAMSci, prof. S.V. Gautier), Moscow, Russian Federation


V. V. Dolgov
Department clinical laboratory diagnostic (Head – prof. V.V. Dolgov) Russian Medical Academy of Postgraduate Education (Rector – academician of RAMSci, prof. L.K. Moshetova), Moscow, Russian Federation


References

1. Шевченко О.П., Кормер А.Я. Патогенез // Болезнь коронарных артерий пересаженного сердца; под ред. В.И. Шумакова. М.: Медицинское информационное агентство, 2008: 12–38.

2. Shevchenko O.P., Kormer A.Ya. Pathogenesis // Shu- makov V.I. Editor. Coronary arteria disease of trans- planted heart. M.: Medical Information Agency, 2008: 12–38.

3. Osto E., Castellani C., Fadini G.P., Baesso I., Gambi- no A., Agostini C., Avogaro A., Gerosa G., Thiene G., Ili- ceto S., Angelini A., Tona F. Impaired endothelial proge- nitor cell recruitment may contribute to heart transplant microvasculopathy // J. Heart Lung Transplant. 2011; 30: 70–76.

4. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Wacla- wiw M.A., Quyyumi A.A., Finkel T. Circulating endothe- lial progenitor cells, vascular function, and cardiovascu- lar risk // N. Engl. J. Med. 2003; 348: 593–600.

5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for an- giogenesis. Science. 1997; 275: 964–967.

6. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moo- re M.A., Storb R.F., Hammond W.P. Evidence for cir- culating bone marrow-derived endothelial cells. Blood. 1998; 92: 362–367.

7. Feng Y., Jacobs F., Van Craeyveld E., Brunaud C., Sno- eys J., Tjwa M., Van Linthout S., De Geest B. Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived en- dothelial progenitor cells // Arterioscler. Thromb. Vasc. Biol. 2008; 28: 278–283.

8. Xu Q. Stem cells and transplant arteriosclerosis // Circ. Res. 2008; 102: 1011–1024.

9. Thomas H.E., Parry G., Dark J.H., Arthur H.M., Keav- ney B.D. Circulating endothelial progenitor cell numbers are not associated with donor organ age or allograft va- sculopathy in cardiac transplant recipients // Atheroscle- rosis. 2009; 202: 612–616.

10. Wu K., Mo X., Lu S., Han Z. Retrograde delivery of stem cells: promising delivery strategy for myocardial regene- rative therapy // Clin. Transplant. 2011; 25: 830–833.

11. Urbich C., Dimmeler S. Endothelial progenitor cells functional characterization // Trends. Cardiovasc. Med. 2004; 14: 318–322.

12. Шевченко А.О., Слесарева Ю.С., Шевченко О.П. Лабораторная диагностика повреждения атероскле- ротической бляшки у больных ишемической болез- нью сердца: РАРР-А // Клин. лаб. диагн. 2011; 5: 3–11.

13. Shevchenko A.O., Slesareva Yu.S., Shevchenko O.P. La- boratory diagnostic of atherosclerotic plague demage in patients with ischemic heart disease // Klin. Lab. Diagn. 2011; 5: 3–11.

14. Shevchenko O.P., Khalilulin T.A., Shevchenko A.O., Or- lova O.V., Mirankov B.L., Kazakov E.N., Kormer A.J., Gautier S.V. Comparision of predictive significance of soluble CD40 ligand, pregnancy-associated plasma protein A, and placental growth factor for graft failure development after heart transplantation // J. Heart Lung Transplant. 2012; 31 (4S): 172–173.

15. Wojakowski W., Tendera M., Kucia M., Zuba-Sur- ma E., Paczkowska E., Ciosek J., Hałasa M., Król M., Kazmierski M., Buszman P., Ochała A., Ratajczak J., Machaliński B., Ratajczak M.Z. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryo- nic-like stem cells in patients with acute myocardial in- farction. J. Am. Col. Cardiol. 2009; 53: 1–9.

16. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajo- li I., Rosso R., De Ferrari G.M., Ferlini M., Goffredo L., Bertoletti A., Klersy C., Pecci A., Moratti R., Tavazzi L. Increased circulating hematopoietic and endothelial pro- genitor cells in the early phase of acute myocardial in- farction // Blood. 2005; 105: 199–206.

17. Nevskaya T., Bykovskaia S., Lyssuk E., Shakhov I., Za- prjagaeva M., Mach E., Ananieva L., Guseva N., Nas- sonov E. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations // Clinical and Expe- rimental Rheumatology. 2008; 26: 421–429.

18. Lemoli R.M., D’Addio A. Hematopoietic stem cell mobi- lization // Haematologica. 2008; 93: 321–324.

19. Курабекова Р.М., Луговская С.А., Наумова Е.В., Ци- рульникова О.М., Цирульникова И.Е., Гичкун О.Е., Ан- дриянова А.А., Шмерко Н.П., Шевченко О.П. Анализ связи количества гемопоэтических стволовых клеток в крови с лабораторными показателями состояния гепатобилиарной системы у детей с врожденными и наследственными заболеваниями печени // Клин. лаб. диагн. 2012;7: 28–31.

20. Kurabekova R.M., Lugovskaia S.A., Naumova E.V., Tsirul’nikova O.M., Gichkun O.E., Andriianova A.A., Shmerko N.P., Shevchenko O.P. The analysis of relati- onship between numbers of hemopoietic hematoblasts and laboratory indicators of state of hepatobiliary sys- tem in children with congenital and hereditary diseases of liver // Klin. Lab. Diagn. 2012; 7: 28–31.

21. Pamukcu B., Lip G.Y., Snezhitskiy V., Shantsila E. The CD40-CD40L system in cardiovascular disease // Ann. Med. 2011; 43: 331–340.


Review

For citations:


Shevchenko O.P., Kurabekova R.M., Naumova E.V., Lugovskaya S.A., Spirina E.A., Poptsov V.N., Olefirenko G.A., Dolgov V.V. RELATIONSHIP BETWEEN CD34/CD45 POSITIVE CELLS CONCENTRATION IN BLOOD OF HEART RECIPIENTS AND LEVEL OF GRAFT VASCULOPATHY RISK BIOMARKERS. Russian Journal of Transplantology and Artificial Organs. 2013;15(2):44-49. (In Russ.) https://doi.org/10.15825/1995-1191-2013-2-44-49

Views: 1349


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)